Integrating Reliable Pt–S Bond-Mediated 3D DNA Nanomachine with Magnetic Separation in a Homogeneous Electrochemical Strategy for Exosomal MicroRNA Detection with Low Background and High Sensitivity
Analytical Chemistry · 05.12.2023 · 95 (48) · 17834-17842
DOI: 10.1021/acs.analchem.3c03914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 21.11.2023. Verfasst von Limin Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, People's Republic of China. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques. Die Arbeit wurde bisher 152-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, Taishan Scholar Foundation of Shandong Province, Qingdao Agricultural University.
Abstract (Originalsprache)
Precise and sensitive analysis of exosomal microRNA (miRNA) is of great importance for noninvasive early disease diagnosis, but it remains a great challenge to detect exosomal miRNA in human blood samples because of their small size, high sequence homology, and low abundance. Herein, we integrated reliable Pt-S bond-mediated three-dimensional (3D) DNA nanomachine and magnetic separation in a homogeneous electrochemical strategy for the detection of exosomal miRNA with low background and high sensitivity. The 3D DNA nanomachine was easily prepared via a facile and rapid freezing method, and it was capable of resisting the influence of biothiols, thus endowing it with high stability. Notably, the as-developed magnetic 3D DNA nanomachine not only enabled the detection system to have a low background but also coupled with liposome nanocarriers to synergistically amplify the current signal. Consequently, by ingeniously combining the low background and multiple signal-amplification strategies in homogeneous electrochemical biosensing, highly sensitive detection of exosomal miRNA was successfully achieved. More significantly, with good anti-interference ability, the as-proposed method could effectively discriminate plasma samples from cancer patients and healthy subjects, thus showing a high potential for application in the nondestructive early clinical diagnosis of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, People's Republic of China.
Förderung
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
- Taishan Scholar Foundation of Shandong Province
- Qingdao Agricultural University
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Yang, L., Guo, H., Gao, Q., Hou, T., Zhang, J., Liu, X., & Li, F. (2023). Integrating Reliable Pt–S Bond-Mediated 3D DNA Nanomachine with Magnetic Separation in a Homogeneous Electrochemical Strategy for Exosomal MicroRNA Detection with Low Background and High Sensitivity. Analytical Chemistry, 95(48), 17834-17842. https://doi.org/10.1021/acs.analchem.3c03914
Vancouver
Yang L, Guo H, Gao Q, Hou T, Zhang J, Liu X, et al. Integrating Reliable Pt–S Bond-Mediated 3D DNA Nanomachine with Magnetic Separation in a Homogeneous Electrochemical Strategy for Exosomal MicroRNA Detection with Low Background and High Sensitivity. Analytical Chemistry. 2023;95(48):17834-17842. doi:10.1021/acs.analchem.3c03914
BibTeX
@article{Yang2023,
author = {Yang, Limin and Guo, Heng and Gao, Qian and Hou, Ting and Zhang, Jingang and Liu, Xiaojuan and Li, Feng},
title = {Integrating Reliable Pt–S Bond-Mediated 3D DNA Nanomachine with Magnetic Separation in a Homogeneous Electrochemical Strategy for Exosomal MicroRNA Detection with Low Background and High Sensitivity},
journal = {Analytical Chemistry},
year = {2023},
volume = {95},
number = {48},
pages = {17834--17842},
doi = {10.1021/acs.analchem.3c03914}
}
EUVIMED